Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Vaccines

  Free Subscription


Articles published in JAMA

Retrieve available abstracts of 161 articles:
HTML format



Single Articles


    November 2021
  1. RUBIN R
    COVID-19 Vaccine Makers Plan for Annual Boosters, but It's Not Clear They'll Be Needed.
    JAMA. 2021 Nov 24. pii: 2786818. doi: 10.1001/jama.2021.21291.
    PubMed    


  2. RUBIN R
    Substance Use Disorders and COVID-19 Vaccine Response.
    JAMA. 2021;326:2000.
    PubMed    


  3. KUEHN BM
    COVID-19 Vaccine Highly Effective Against Adolescent Hospitalizations.
    JAMA. 2021;326:2002.
    PubMed    


  4. KUEHN BM
    Unhygienic Practices Lead to Routine Vaccination-Linked Infections.
    JAMA. 2021;326:2002.
    PubMed    


  5. JABAGI MJ, Botton J, Bertrand M, Weill A, et al
    Myocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine in People Aged 75 Years or Older.
    JAMA. 2021 Nov 22. pii: 2786667. doi: 10.1001/jama.2021.21699.
    PubMed    


  6. ABBASI J
    Flu Vaccine Candidate Elicits Enhanced Immune Response.
    JAMA. 2021;326:1784.
    PubMed    


  7. ABBASI J
    Pfizer Launches Phase 1 mRNA Flu Vaccine Trial.
    JAMA. 2021;326:1784.
    PubMed    


  8. ABBASI J
    "Polymutant" Spike Points Way Toward More Durable COVID-19 Vaccine.
    JAMA. 2021;326:1784.
    PubMed    



  9. Routine Smallpox Vaccination.
    JAMA. 2021;326:1876.
    PubMed    


  10. ELIAKIM-RAZ N, Leibovici-Weisman Y, Stemmer A, Ness A, et al
    Antibody Titers Before and After a Third Dose of the SARS-CoV-2 BNT162b2 Vaccine in Adults Aged >/=60 Years.
    JAMA. 2021 Nov 5. pii: 2786096. doi: 10.1001/jama.2021.19885.
    PubMed    


  11. MOSS WJ, Gostin LO, Nuzzo JB
    Pediatric COVID-19 Vaccines: What Parents, Practitioners, and Policy Makers Need to Know.
    JAMA. 2021 Nov 5. pii: 2786095. doi: 10.1001/jama.2021.20734.
    PubMed    


  12. KLOMPAS M
    Understanding Breakthrough Infections Following mRNA SARS-CoV-2 Vaccination.
    JAMA. 2021 Nov 4. pii: 2786040. doi: 10.1001/jama.2021.19063.
    PubMed    


  13. TENFORDE MW, Self WH, Adams K, Gaglani M, et al
    Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity.
    JAMA. 2021 Nov 4. pii: 2786039. doi: 10.1001/jama.2021.19499.
    PubMed     Abstract available


  14. CROWE EH
    The Taste of Hope.
    JAMA. 2021;326:1683-1684.
    PubMed    


  15. ZHONG D, Xiao S, Debes AK, Egbert ER, et al
    Durability of Antibody Levels After Vaccination With mRNA SARS-CoV-2 Vaccine in Individuals With or Without Prior Infection.
    JAMA. 2021 Nov 1. pii: 2785919. doi: 10.1001/jama.2021.19996.
    PubMed    


  16. ABU-RADDAD LJ, Chemaitelly H, Ayoub HH, Yassine HM, et al
    Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in Qatar.
    JAMA. 2021 Nov 1. pii: 2785918. doi: 10.1001/jama.2021.19623.
    PubMed     Abstract available


    October 2021
  17. ABBASI J
    The Flawed Science of Antibody Testing for SARS-CoV-2 Immunity.
    JAMA. 2021 Oct 21. pii: 2785530. doi: 10.1001/jama.2021.18919.
    PubMed    


  18. RUBIN R
    Trying to Block SARS-CoV-2 Transmission With Intranasal Vaccines.
    JAMA. 2021 Oct 14. pii: 2785303. doi: 10.1001/jama.2021.18143.
    PubMed    


  19. SZILAGYI PG, Thomas K, Shah MD, Vizueta N, et al
    Changes in COVID-19 Vaccine Intent From April/May to June/July 2021.
    JAMA. 2021 Oct 13. pii: 2785290. doi: 10.1001/jama.2021.18761.
    PubMed    


  20. ABBASI J
    India's New COVID-19 DNA Vaccine for Adolescents and Adults Is a First.
    JAMA. 2021;326:1365.
    PubMed    


  21. ABBASI J
    Moderna's mRNA Vaccine for Seasonal Flu Enters Clinical Trials.
    JAMA. 2021;326:1365.
    PubMed    


  22. ABBASI J
    Vaccine-Induced SARS-CoV-2 Antibodies in Inflammatory Diseases.
    JAMA. 2021;326:1365.
    PubMed    


  23. KUEHN BM
    HPV Vaccination Coverage Has Increased Among Adolescents.
    JAMA. 2021;326:1366.
    PubMed    


  24. WOO EJ, Mba-Jonas A, Dimova RB, Alimchandani M, et al
    Association of Receipt of the Ad26.COV2.S COVID-19 Vaccine With Presumptive Guillain-Barre Syndrome, February-July 2021.
    JAMA. 2021 Oct 7. pii: 2785009. doi: 10.1001/jama.2021.16496.
    PubMed     Abstract available


    September 2021
  25. RUBIN R
    COVID-19 Vaccine Nasal Spray.
    JAMA. 2021;326:1138.
    PubMed    


  26. KRONMAL SL
    Shots in Arms.
    JAMA. 2021;326:1151-1152.
    PubMed    


  27. ABBASI J
    SARS-CoV-2 Variant Antibodies Wane 6 Months After Vaccination.
    JAMA. 2021;326:901.
    PubMed    


  28. KUEHN BM
    Adolescent Myocarditis After COVID-19 Vaccination Is Rare.
    JAMA. 2021;326:902.
    PubMed    


  29. KHARBANDA EO, Haapala J, DeSilva M, Vazquez-Benitez G, et al
    Spontaneous Abortion Following COVID-19 Vaccination During Pregnancy.
    JAMA. 2021 Sep 8. pii: 2784193. doi: 10.1001/jama.2021.15494.
    PubMed    


  30. SLOMSKI A
    Most Fully Vaccinated Patients With Cancer Have SARS-CoV-2 Antibodies.
    JAMA. 2021;326:800.
    PubMed    


  31. BLUMENTHAL KG, Phadke NA, Bates DW
    Safety Surveillance of COVID-19 mRNA Vaccines Through the Vaccine Safety Datalink.
    JAMA. 2021 Sep 3. pii: 2784017. doi: 10.1001/jama.2021.14808.
    PubMed    


  32. KLEIN NP, Lewis N, Goddard K, Fireman B, et al
    Surveillance for Adverse Events After COVID-19 mRNA Vaccination.
    JAMA. 2021 Sep 3. pii: 2784015. doi: 10.1001/jama.2021.15072.
    PubMed     Abstract available


  33. JONES JM, Stone M, Sulaeman H, Fink RV, et al
    Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021.
    JAMA. 2021 Sep 2. pii: 2784013. doi: 10.1001/jama.2021.15161.
    PubMed     Abstract available


    August 2021
  34. STEENSELS D, Pierlet N, Penders J, Mesotten D, et al
    Comparison of SARS-CoV-2 Antibody Response Following Vaccination With BNT162b2 and mRNA-1273.
    JAMA. 2021 Aug 30. pii: 2783797. doi: 10.1001/jama.2021.15125.
    PubMed    


  35. RUBIN R
    Influenza's Unprecedented Low Profile During COVID-19 Pandemic Leaves Experts Wondering What This Flu Season Has in Store.
    JAMA. 2021 Aug 25. pii: 2783644. doi: 10.1001/jama.2021.14131.
    PubMed    


  36. DETSKY AS, Bogoch II
    COVID-19 in Canada: Experience and Response to Waves 2 and 3.
    JAMA. 2021 Aug 23. pii: 2783610. doi: 10.1001/jama.2021.14797.
    PubMed    


  37. DEL RIO C, Malani PN, Omer SB
    Confronting the Delta Variant of SARS-CoV-2, Summer 2021.
    JAMA. 2021 Aug 18. pii: 2783478. doi: 10.1001/jama.2021.14811.
    PubMed    


  38. EVANS A, Webster J, Flores G
    Partnering With the Faith-Based Community to Address Disparities in COVID-19 Vaccination Rates and Outcomes Among US Black and Latino Populations.
    JAMA. 2021;326:609-610.
    PubMed    


  39. SCHAEFER GO, Leland RJ, Emanuel EJ
    Making Vaccines Available to Other Countries Before Offering Domestic Booster Vaccinations.
    JAMA. 2021 Aug 12. pii: 2783234. doi: 10.1001/jama.2021.13226.
    PubMed    


  40. ABBASI J
    Oldest Adults Need 2 mRNA Vaccine Doses to Neutralize SARS-CoV-2.
    JAMA. 2021;326:473.
    PubMed    


  41. ABBASI J
    COVID-19 mRNA Vaccines Blunt Breakthrough Infection Severity.
    JAMA. 2021;326:473.
    PubMed    


  42. DIAZ GA, Parsons GT, Gering SK, Meier AR, et al
    Myocarditis and Pericarditis After Vaccination for COVID-19.
    JAMA. 2021 Aug 4. pii: 2782900. doi: 10.1001/jama.2021.13443.
    PubMed    


    July 2021
  43. ABBASI J
    Uberantibodies From Recovered COVID-19 Patients Could Spur New Therapeutics and Vaccines.
    JAMA. 2021 Jul 28. pii: 2782673. doi: 10.1001/jama.2021.12915.
    PubMed    


  44. RUBIN R
    Higher Medicare Payments for In-home COVID-19 Vaccinations.
    JAMA. 2021;326:298.
    PubMed    


  45. KUEHN BM
    Resurgence of Pertussis Linked With Switch to Acellular Vaccine.
    JAMA. 2021;326:300.
    PubMed    


  46. BENOTMANE I, Gautier G, Perrin P, Olagne J, et al
    Antibody Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients With Minimal Serologic Response to 2 Doses.
    JAMA. 2021 Jul 23. pii: 2782538. doi: 10.1001/jama.2021.12339.
    PubMed    


  47. BATES TA, Leier HC, Lyski ZL, Goodman JR, et al
    Age-Dependent Neutralization of SARS-CoV-2 and P.1 Variant by Vaccine Immune Serum Samples.
    JAMA. 2021 Jul 21. pii: 2782428. doi: 10.1001/jama.2021.11656.
    PubMed    


  48. ABBASI J
    Study Suggests Lasting Immunity After COVID-19, With a Big Boost From Vaccination.
    JAMA. 2021 Jul 14. pii: 2782139. doi: 10.1001/jama.2021.11717.
    PubMed    


  49. GOLDSHTEIN I, Nevo D, Steinberg DM, Rotem RS, et al
    Association Between BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant Women.
    JAMA. 2021 Jul 12. pii: 2782047. doi: 10.1001/jama.2021.11035.
    PubMed     Abstract available


  50. NUTI SV, Armstrong K
    Lay Epidemiology and Vaccine Acceptance.
    JAMA. 2021 Jul 7. pii: 2781943. doi: 10.1001/jama.2021.11130.
    PubMed    


  51. WALKEY AJ, Law A, Bosch NA
    Lottery-Based Incentive in Ohio and COVID-19 Vaccination Rates.
    JAMA. 2021 Jul 2. pii: 2781792. doi: 10.1001/jama.2021.11048.
    PubMed    


  52. SANCHEZ VAN KAMMEN M, Heldner MR, Brodard J, Scutelnic A, et al
    Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 Pandemic.
    JAMA. 2021 Jul 2. pii: 2781791. doi: 10.1001/jama.2021.9889.
    PubMed     Abstract available


  53. KAVANAGH MM, Gostin LO, Sunder M
    Sharing Technology and Vaccine Doses to Address Global Vaccine Inequity and End the COVID-19 Pandemic.
    JAMA. 2021 Jul 1. pii: 2781756. doi: 10.1001/jama.2021.10823.
    PubMed    


  54. PERSAD G, Emanuel EJ
    Ethical Considerations of Offering Benefits to COVID-19 Vaccine Recipients.
    JAMA. 2021 Jul 1. pii: 2781755. doi: 10.1001/jama.2021.11045.
    PubMed    


    June 2021
  55. RUBIN R
    The Search for a Single Vaccine Against Coronaviruses Yet to Come.
    JAMA. 2021 Jun 23. pii: 2781521. doi: 10.1001/jama.2021.9477.
    PubMed    


  56. RUBIN R
    Vaccination in Residential Facilities.
    JAMA. 2021;325:2426.
    PubMed    


  57. GONZALEZ DC, Nassau DE, Khodamoradi K, Ibrahim E, et al
    Sperm Parameters Before and After COVID-19 mRNA Vaccination.
    JAMA. 2021 Jun 17. pii: 2781360. doi: 10.1001/jama.2021.9976.
    PubMed    


  58. BERTOLLINI R, Chemaitelly H, Yassine HM, Al-Thani MH, et al
    Associations of Vaccination and of Prior Infection With Positive PCR Test Results for SARS-CoV-2 in Airline Passengers Arriving in Qatar.
    JAMA. 2021 Jun 9. pii: 2781112. doi: 10.1001/jama.2021.9970.
    PubMed    


  59. AZZIZ-BAUMGARTNER E, Grohskopf L, Patel M
    Realizing the Potential of Maternal Influenza Vaccination.
    JAMA. 2021;325:2257-2259.
    PubMed    


  60. MEHRABADI A, Dodds L, MacDonald NE, Top KA, et al
    Association of Maternal Influenza Vaccination During Pregnancy With Early Childhood Health Outcomes.
    JAMA. 2021;325:2285-2293.
    PubMed     Abstract available


  61. TALBOT TR
    COVID-19 Vaccination of Health Care Personnel as a Condition of Employment: A Logical Addition to Institutional Safety Programs.
    JAMA. 2021 Jun 7. pii: 2781011. doi: 10.1001/jama.2021.8901.
    PubMed    


  62. GOSTIN LO, Shaw J, Salmon DA
    Mandatory SARS-CoV-2 Vaccinations in K-12 Schools, Colleges/Universities, and Businesses.
    JAMA. 2021 Jun 7. pii: 2781010. doi: 10.1001/jama.2021.9342.
    PubMed    


  63. RYAN L
    Vaccinated but Not Protected-Living Immunocompromised During the Pandemic.
    JAMA. 2021 Jun 7. pii: 2781012. doi: 10.1001/jama.2021.9321.
    PubMed    


  64. WOOD S, Schulman K
    When Vaccine Apathy, Not Hesitancy, Drives Vaccine Disinterest.
    JAMA. 2021 Jun 2. pii: 2780792. doi: 10.1001/jama.2021.7707.
    PubMed    


    May 2021
  65. HOTEZ PJ, Narayan KMV
    Restoring Vaccine Diplomacy.
    JAMA. 2021 May 28. pii: 2780640. doi: 10.1001/jama.2021.7439.
    PubMed    


  66. AL KAABI N, Zhang Y, Xia S, Yang Y, et al
    Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical Trial.
    JAMA. 2021 May 26. pii: 2780562. doi: 10.1001/jama.2021.8565.
    PubMed     Abstract available


  67. RUBIN R
    Allergic Reactions to mRNA Vaccines.
    JAMA. 2021;325:2038.
    PubMed    


  68. DALY M, Jones A, Robinson E
    Public Trust and Willingness to Vaccinate Against COVID-19 in the US From October 14, 2020, to March 29, 2021.
    JAMA. 2021 May 24. pii: 2780519. doi: 10.1001/jama.2021.8246.
    PubMed    


  69. UYEKI TM, Wentworth DE, Jernigan DB
    Influenza Activity in the US During the 2020-2021 Season.
    JAMA. 2021 May 24. pii: 2780518. doi: 10.1001/jama.2021.6125.
    PubMed    


  70. COLLIER AY, McMahan K, Yu J, Tostanoski LH, et al
    Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women.
    JAMA. 2021 May 13. pii: 2780202. doi: 10.1001/jama.2021.7563.
    PubMed     Abstract available


  71. ABBASI J
    Personalized Cancer Vaccine Approach Safe in Early Trial.
    JAMA. 2021;325:1825.
    PubMed    


  72. KUEHN BM
    Even Partial COVID-19 Vaccination Protects Nursing Home Residents.
    JAMA. 2021;325:1826.
    PubMed    


  73. KUEHN BM
    Vaccine Dramatically Reduces HPV Infection Among Young Women.
    JAMA. 2021;325:1826.
    PubMed    


  74. TANG L, Hijano DR, Gaur AH, Geiger TL, et al
    Asymptomatic and Symptomatic SARS-CoV-2 Infections After BNT162b2 Vaccination in a Routinely Screened Workforce.
    JAMA. 2021 May 6. pii: 2779854. doi: 10.1001/jama.2021.6564.
    PubMed    


  75. ANGEL Y, Spitzer A, Henig O, Saiag E, et al
    Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers.
    JAMA. 2021 May 6. pii: 2779853. doi: 10.1001/jama.2021.7152.
    PubMed     Abstract available


  76. BOYARSKY BJ, Werbel WA, Avery RK, Tobian AAR, et al
    Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients.
    JAMA. 2021 May 5. pii: 2779852. doi: 10.1001/jama.2021.7489.
    PubMed    


    April 2021
  77. SEE I, Su JR, Lale A, Woo EJ, et al
    US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021.
    JAMA. 2021 Apr 30. pii: 2779731. doi: 10.1001/jama.2021.7517.
    PubMed     Abstract available


  78. KARRON RA, Key NS, Sharfstein JM
    Assessing a Rare and Serious Adverse Event Following Administration of the Ad26.COV2.S Vaccine.
    JAMA. 2021 Apr 30. pii: 2779732. doi: 10.1001/jama.2021.7637.
    PubMed    


  79. RUBIN R
    Vaccination Priorities Delay Shots for Higher-Risk People of Color.
    JAMA. 2021;325:1601.
    PubMed    


  80. RUBIN R
    Medicare Raises Payment for Administering COVID-19 Vaccines.
    JAMA. 2021;325:1601.
    PubMed    


  81. CHEN MM, Mott N, Clark SJ, Harper DM, et al
    HPV Vaccination Among Young Adults in the US.
    JAMA. 2021;325:1673-1674.
    PubMed    


  82. KUEHN BM
    Israel's Real-life Evidence That Vaccine Can Prevent Severe COVID-19.
    JAMA. 2021;325:1603.
    PubMed    


  83. BLAIN H, Tuaillon E, Gamon L, Pisoni A, et al
    Spike Antibody Levels of Nursing Home Residents With or Without Prior COVID-19 3 Weeks After a Single BNT162b2 Vaccine Dose.
    JAMA. 2021 Apr 15. pii: 2778926. doi: 10.1001/jama.2021.6042.
    PubMed    



  84. Experts Discuss COVID-19-Variants and Vaccine Efficacy, Immunosuppressed Patients, and More.
    JAMA. 2021 Apr 14. pii: 2778876. doi: 10.1001/jama.2021.5938.
    PubMed    


  85. ABBASI J
    Data Leak Exposes Early COVID-19 Vaccine Manufacturing Hiccups.
    JAMA. 2021;325:1385.
    PubMed    


  86. PERL SH, Uzan-Yulzari A, Klainer H, Asiskovich L, et al
    SARS-CoV-2-Specific Antibodies in Breast Milk After COVID-19 Vaccination of Breastfeeding Women.
    JAMA. 2021 Apr 12. pii: 2778766. doi: 10.1001/jama.2021.5782.
    PubMed    


  87. GOSTIN LO, Cohen IG, Shaw J
    Digital Health Passes in the Age of COVID-19: Are "Vaccine Passports" Lawful and Ethical?
    JAMA. 2021 Apr 7. pii: 2778526. doi: 10.1001/jama.2021.5283.
    PubMed    


  88. CHAPIN-BARDALES J, Gee J, Myers T
    Reactogenicity Following Receipt of mRNA-Based COVID-19 Vaccines.
    JAMA. 2021 Apr 5. pii: 2778441. doi: 10.1001/jama.2021.5374.
    PubMed    


    March 2021
  89. RUBIN R
    HHS Expands Number of People Who Can Vaccinate Against COVID-19.
    JAMA. 2021;325:1134.
    PubMed    


  90. GOSTIN LO
    The Coronavirus Pandemic 1 Year On-What Went Wrong?
    JAMA. 2021;325:1132-1133.
    PubMed    


  91. EDARA VV, Hudson WH, Xie X, Ahmed R, et al
    Neutralizing Antibodies Against SARS-CoV-2 Variants After Infection and Vaccination.
    JAMA. 2021 Mar 19. pii: 2777898. doi: 10.1001/jama.2021.4388.
    PubMed    



  92. Experts Discuss COVID-19-Vaccine Questions, School Openings, and More.
    JAMA. 2021 Mar 17. pii: 2777786. doi: 10.1001/jama.2021.4121.
    PubMed    


  93. RUBIN R
    COVID-19 Vaccines vs Variants-Determining How Much Immunity Is Enough.
    JAMA. 2021 Mar 17. pii: 2777785. doi: 10.1001/jama.2021.3370.
    PubMed    


  94. WILENSKY GR
    2020 Revealed How Poorly the US Was Prepared for COVID-19-and Future Pandemics.
    JAMA. 2021;325:1029-1030.
    PubMed    


  95. BOYARSKY BJ, Werbel WA, Avery RK, Tobian AAR, et al
    Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients.
    JAMA. 2021 Mar 15. pii: 2777685. doi: 10.1001/jama.2021.4385.
    PubMed    


  96. WILF-MIRON R, Myers V, Saban M
    Incentivizing Vaccination Uptake: The "Green Pass" Proposal in Israel.
    JAMA. 2021 Mar 15. pii: 2777686. doi: 10.1001/jama.2021.4300.
    PubMed    


  97. STEPHENSON KE, Le Gars M, Sadoff J, de Groot AM, et al
    Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19.
    JAMA. 2021 Mar 11. pii: 2777598. doi: 10.1001/jama.2021.3645.
    PubMed     Abstract available


  98. CHRISTIE A, Mbaeyi SA, Walensky RP
    CDC Interim Recommendations for Fully Vaccinated People: An Important First Step.
    JAMA. 2021 Mar 10. pii: 2777536. doi: 10.1001/jama.2021.4367.
    PubMed    


  99. BLUMENTHAL KG, Robinson LB, Camargo CA Jr, Shenoy ES, et al
    Acute Allergic Reactions to mRNA COVID-19 Vaccines.
    JAMA. 2021 Mar 8. pii: 2777417. doi: 10.1001/jama.2021.3976.
    PubMed    


  100. MOORE JP
    Approaches for Optimal Use of Different COVID-19 Vaccines: Issues of Viral Variants and Vaccine Efficacy.
    JAMA. 2021 Mar 4. pii: 2777390. doi: 10.1001/jama.2021.3465.
    PubMed    


  101. DEL RIO C, Malani P
    COVID-19 in 2021-Continuing Uncertainty.
    JAMA. 2021 Mar 4. pii: 2777391. doi: 10.1001/jama.2021.3760.
    PubMed    


  102. MURRAY CJL, Piot P
    The Potential Future of the COVID-19 Pandemic: Will SARS-CoV-2 Become a Recurrent Seasonal Infection?
    JAMA. 2021 Mar 3. pii: 2777343. doi: 10.1001/jama.2021.2828.
    PubMed    


  103. SAADAT S, Tehrani ZR, Logue J, Newman M, et al
    Binding and Neutralization Antibody Titers After a Single Vaccine Dose in Health Care Workers Previously Infected With SARS-CoV-2.
    JAMA. 2021 Mar 1. pii: 2777171. doi: 10.1001/jama.2021.3341.
    PubMed    


  104. LIVINGSTON EH, Malani PN, Creech CB
    The Johnson & Johnson Vaccine for COVID-19.
    JAMA. 2021 Mar 1. pii: 2777172. doi: 10.1001/jama.2021.2927.
    PubMed    


    February 2021
  105. CREECH CB, Walker SC, Samuels RJ
    SARS-CoV-2 Vaccines.
    JAMA. 2021 Feb 26. pii: 2777059. doi: 10.1001/jama.2021.3199.
    PubMed    


  106. GHARPURE R, Patel A, Link-Gelles R
    First-Dose COVID-19 Vaccination Coverage Among Skilled Nursing Facility Residents and Staff.
    JAMA. 2021 Feb 24. pii: 2777023. doi: 10.1001/jama.2021.2352.
    PubMed    


  107. RUBIN R
    Pregnant People's Paradox-Excluded From Vaccine Trials Despite Having a Higher Risk of COVID-19 Complications.
    JAMA. 2021 Feb 24. pii: 2777024. doi: 10.1001/jama.2021.2264.
    PubMed    


  108. RUBIN R
    The Price of Success-How to Evaluate COVID-19 Vaccines When They're Available Outside of Clinical Trials.
    JAMA. 2021 Feb 18. pii: 2776787. doi: 10.1001/jama.2021.0641.
    PubMed    


  109. WALENSKY RP, Walke HT, Fauci AS
    SARS-CoV-2 Variants of Concern in the United States-Challenges and Opportunities.
    JAMA. 2021 Feb 17. pii: 2776739. doi: 10.1001/jama.2021.2294.
    PubMed    


  110. KUEHN BM
    High-Income Countries Have Secured the Bulk of COVID-19 Vaccines.
    JAMA. 2021;325:612.
    PubMed    


  111. SHARFSTEIN JM, Goodman JL, Borio L
    The US Regulatory System and COVID-19 Vaccines: The Importance of a Strong and Capable FDA.
    JAMA. 2021 Feb 15. pii: 2776658. doi: 10.1001/jama.2021.1961.
    PubMed    


  112. SHIMABUKURO TT, Cole M, Su JR
    Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US-December 14, 2020-January 18, 2021.
    JAMA. 2021 Feb 12. pii: 2776557. doi: 10.1001/jama.2021.1967.
    PubMed    



  113. Experts Discuss COVID-19-Vaccine Doses, Virus Variants, and More.
    JAMA. 2021 Feb 10. pii: 2776539. doi: 10.1001/jama.2021.1101.
    PubMed    


  114. BIANCHI DW, Kaeser L, Cernich AN
    Involving Pregnant Individuals in Clinical Research on COVID-19 Vaccines.
    JAMA. 2021 Feb 10. pii: 2776540. doi: 10.1001/jama.2021.1865.
    PubMed    


  115. ADHIKARI EH, Spong CY
    COVID-19 Vaccination in Pregnant and Lactating Women.
    JAMA. 2021 Feb 8. pii: 2776449. doi: 10.1001/jama.2021.1658.
    PubMed    


  116. RASMUSSEN SA, Jamieson DJ
    Pregnancy, Postpartum Care, and COVID-19 Vaccination in 2021.
    JAMA. 2021 Feb 8. pii: 2776447. doi: 10.1001/jama.2021.1683.
    PubMed    


  117. MEISSNER HC
    A Viral Pandemic, Vaccine Safety, and Compensation for Adverse Events.
    JAMA. 2021 Feb 5. pii: 2776308. doi: 10.1001/jama.2020.26792.
    PubMed    


  118. LIVINGSTON EH
    Necessity of 2 Doses of the Pfizer and Moderna COVID-19 Vaccines.
    JAMA. 2021 Feb 3. pii: 2776229. doi: 10.1001/jama.2021.1375.
    PubMed    


    January 2021
  119. JEAN-JACQUES M, Bauchner H
    Vaccine Distribution-Equity Left Behind?
    JAMA. 2021 Jan 29. pii: 2776053. doi: 10.1001/jama.2021.1205.
    PubMed    


  120. MOORE JP, Offit PA
    SARS-CoV-2 Vaccines and the Growing Threat of Viral Variants.
    JAMA. 2021 Jan 28. pii: 2776039. doi: 10.1001/jama.2021.1114.
    PubMed    


  121. LONGHURST CA, Kremer B, Maysent PS
    Rapid Implementation of a Vaccination Superstation.
    JAMA. 2021 Jan 28. pii: 2776038. doi: 10.1001/jama.2021.0801.
    PubMed    


  122. SHIMABUKURO T, Nair N
    Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine.
    JAMA. 2021 Jan 21. pii: 2775646. doi: 10.1001/jama.2021.0600.
    PubMed    


  123. KUEHN BM
    Drop in Vaccination Causes Surge in Global Measles Cases, Deaths.
    JAMA. 2021;325:213.
    PubMed    


  124. ABBASI J
    Broad, Durable Antibody Response in Universal Flu Vaccine Trial.
    JAMA. 2021;325:121.
    PubMed    


  125. LARGENT EA, Miller FG
    Problems With Paying People to Be Vaccinated Against COVID-19.
    JAMA. 2021 Jan 6. pii: 2775005. doi: 10.1001/jama.2020.27121.
    PubMed    


  126. LAURING AS, Hodcroft EB
    Genetic Variants of SARS-CoV-2-What Do They Mean?
    JAMA. 2021 Jan 6. pii: 2775006. doi: 10.1001/jama.2020.27124.
    PubMed    


  127. GOSTIN LO
    A 7-Point Action Agenda to End the COVID-19 Pandemic for President-elect Biden.
    JAMA. 2021;325:17-18.
    PubMed    


    December 2020
  128. GOSTIN LO, Salmon DA, Larson HJ
    Mandating COVID-19 Vaccines.
    JAMA. 2020 Dec 29. pii: 2774712. doi: 10.1001/jama.2020.26553.
    PubMed    


  129. SZILAGYI PG, Thomas K, Shah MD, Vizueta N, et al
    National Trends in the US Public's Likelihood of Getting a COVID-19 Vaccine-April 1 to December 8, 2020.
    JAMA. 2020 Dec 29. pii: 2774711. doi: 10.1001/jama.2020.26419.
    PubMed    


  130. RUBIN R
    Pharmacies Partner With HHS to Provide COVID-19 Vaccines.
    JAMA. 2020;324:2475.
    PubMed    


  131. KUEHN BM
    Global Regulators Set Standards for Safe Vaccines.
    JAMA. 2020;324:2356.
    PubMed    



  132. Experts Discuss COVID-19: Vaccine Allocation, Placebo Groups, and More.
    JAMA. 2020;324:2354-2355.
    PubMed    


  133. KRIST AH, Davidson KW, Mangione CM, Barry MJ, et al
    Screening for Hepatitis B Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2020;324:2415-2422.
    PubMed     Abstract available


  134. JIN J
    Screening for Hepatitis B in Nonpregnant Adolescents and Adults.
    JAMA. 2020;324:2452.
    PubMed    


  135. RID A, Lipsitch M, Miller FG
    The Ethics of Continuing Placebo in SARS-CoV-2 Vaccine Trials.
    JAMA. 2020 Dec 14. pii: 2774382. doi: 10.1001/jama.2020.25053.
    PubMed    


  136. VOLPP KG, Loewenstein G, Buttenheim AM
    Behaviorally Informed Strategies for a National COVID-19 Vaccine Promotion Program.
    JAMA. 2020 Dec 14. pii: 2774381. doi: 10.1001/jama.2020.24036.
    PubMed    


  137. JOFFE S
    Evaluating SARS-CoV-2 Vaccines After Emergency Use Authorization or Licensing of Initial Candidate Vaccines.
    JAMA. 2020 Dec 14. pii: 2774383. doi: 10.1001/jama.2020.25127.
    PubMed    


  138. PATEL MM, Uyeki TM
    Influenza Vaccine for Patients With High-risk Cardiovascular Disease.
    JAMA. 2020 Dec 4. pii: 2773988. doi: 10.1001/jama.2020.23948.
    PubMed    


  139. VARDENY O, Kim K, Udell JA, Joseph J, et al
    Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease: A Randomized Clinical Trial.
    JAMA. 2020 Dec 4. pii: 2773989. doi: 10.1001/jama.2020.23649.
    PubMed     Abstract available


  140. RODRIGUES FMP, Marlow R, Simoes MJ, Danon L, et al
    Association of Use of a Meningococcus Group B Vaccine With Group B Invasive Meningococcal Disease Among Children in Portugal.
    JAMA. 2020;324:2187-2194.
    PubMed     Abstract available


    November 2020
  141. DESAI AN, Majumder MS
    What Is Herd Immunity?
    JAMA. 2020;324:2113.
    PubMed    


  142. LURIE N, Experton B
    How to Leverage the Medicare Program for a COVID-19 Vaccination Campaign.
    JAMA. 2020 Nov 19. pii: 2773348. doi: 10.1001/jama.2020.22720.
    PubMed    


  143. LENIS AT, Lec PM, Chamie K, Mshs MD, et al
    Bladder Cancer: A Review.
    JAMA. 2020;324:1980-1991.
    PubMed     Abstract available


  144. SLOMSKI A
    New Guideline Calls for Cervical Cancer Screening to Begin at Age 25 Years.
    JAMA. 2020 Nov 6. pii: 2772859. doi: 10.1001/jama.2020.21706.
    PubMed    


  145. UYEKI TM
    High-risk Groups for Influenza Complications.
    JAMA. 2020 Nov 2. pii: 2772692. doi: 10.1001/jama.2020.21869.
    PubMed    


  146. UYEKI TM, Santoli J, Jernigan DB
    Preparing for the 2020-2021 Influenza Season.
    JAMA. 2020 Nov 2. pii: 2772691. doi: 10.1001/jama.2020.21849.
    PubMed    


    October 2020
  147. JAKLEVIC MC
    Nursing Homes' Next Test-Vaccinating Workers Against COVID-19.
    JAMA. 2020 Oct 28. pii: 2772581. doi: 10.1001/jama.2020.21354.
    PubMed    


  148. BELL BP, Romero JR, Lee GM
    Scientific and Ethical Principles Underlying Recommendations From the Advisory Committee on Immunization Practices for COVID-19 Vaccination Implementation.
    JAMA. 2020 Oct 22. pii: 2772326. doi: 10.1001/jama.2020.20847.
    PubMed    


  149. LEE GM, Romero JR, Bell BP
    Postapproval Vaccine Safety Surveillance for COVID-19 Vaccines in the US.
    JAMA. 2020 Oct 16. pii: 2772137. doi: 10.1001/jama.2020.19692.
    PubMed    


  150. GOODMAN JL, Grabenstein JD, Braun MM
    Answering Key Questions About COVID-19 Vaccines.
    JAMA. 2020 Oct 16. pii: 2772138. doi: 10.1001/jama.2020.20590.
    PubMed    


  151. PATEL MM, Jackson ML, Ferdinands J
    Postlicensure Evaluation of COVID-19 Vaccines.
    JAMA. 2020 Oct 16. pii: 2772136. doi: 10.1001/jama.2020.19328.
    PubMed    


  152. SCHMIDT H, Gostin LO, Williams MA
    Is It Lawful and Ethical to Prioritize Racial Minorities for COVID-19 Vaccines?
    JAMA. 2020 Oct 14. pii: 2771874. doi: 10.1001/jama.2020.20571.
    PubMed    



  153. Influenza Vaccine for 2020-2021.
    JAMA. 2020 Oct 2. pii: 2771510. doi: 10.1001/jama.2020.19507.
    PubMed    


    September 2020
  154. STEPHENS DS, McElrath MJ
    COVID-19 and the Path to Immunity.
    JAMA. 2020 Sep 11. pii: 2770758. doi: 10.1001/jama.2020.16656.
    PubMed    


    August 2020
  155. SOLOMON DA, Sherman AC, Kanjilal S
    Influenza in the COVID-19 Era.
    JAMA. 2020 Aug 14. pii: 2769676. doi: 10.1001/jama.2020.14661.
    PubMed    


    July 2020
  156. WIERSINGA WJ, Rhodes A, Cheng AC, Peacock SJ, et al
    Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.
    JAMA. 2020 Jul 10. pii: 2768391. doi: 10.1001/jama.2020.12839.
    PubMed     Abstract available


  157. DESAI AN, Kim AY
    Management of Hepatitis A in 2020-2021.
    JAMA. 2020 Jul 6. pii: 2768154. doi: 10.1001/jama.2020.4017.
    PubMed    


    May 2020
  158. DEL RIO C, Malani P
    Translating Science on COVID-19 to Improve Clinical Care and Support the Public Health Response.
    JAMA. 2020 May 22. pii: 2766600. doi: 10.1001/jama.2020.9252.
    PubMed    


  159. HALL MA, Studdert DM
    Privileges and Immunity Certification During the COVID-19 Pandemic.
    JAMA. 2020 May 6. pii: 2765835. doi: 10.1001/jama.2020.7712.
    PubMed    


  160. PERSAD G, Emanuel EJ
    The Ethics of COVID-19 Immunity-Based Licenses ("Immunity Passports").
    JAMA. 2020 May 6. pii: 2765836. doi: 10.1001/jama.2020.8102.
    PubMed    


    February 2020
  161. WONG JEL, Leo YS, Tan CC
    COVID-19 in Singapore-Current Experience: Critical Global Issues That Require Attention and Action.
    JAMA. 2020 Feb 20. pii: 2761890. doi: 10.1001/jama.2020.2467.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: